abiraterone,olaparib
astrazeneca,merck
['propel', 'gu ', 'merck', 'astrazeneca', '$azn']
$azn astrazeneca and merck present final results of key secondary overall survival endpoint from phase iii propel trial at asco gu cancers symposium 45 seconds delayed.
Democratizing insights.

Not investment advice.